J-Pharma

IPO

Developing innovative new drugs targeting SLC transporters

Public · Tokyo, Japan · Founded 2005 · $49.6M raised

Headquarters
Tokyo
Employees
1–10
Founded
2005
Business Model
B2B
Total Funding
$49.6M
Last Round
$23.7M Venture RoundApr 2025
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 4 investors for this company. The full record is or through the API.

About

J-Pharma Co., Ltd. is a Tokyo-based clinical-stage biopharmaceutical company founded in December 2005, focused on developing novel drugs that target SLC (solute carrier) membrane transporters to address unmet medical needs. The company's lead compound, Nanvuranlat (JPH203), is a first-in-class LAT1 inhibitor currently in global Phase III clinical trials for the second-line treatment of biliary tract cancer, having received FDA Orphan Drug Designation in 2022 and FDA IND clearance in 2024. J-Pharma also advances JPH034, a CNS-penetrant LAT1 inhibitor entering Phase I trials for multiple sclerosis. The company was founded based on research by Hitoshi Endou at Kyorin University and listed on the Tokyo Stock Exchange Growth Market in March 2026.

Summary

J-Pharma is a Biotech company based in Tokyo, Japan, founded in 2005. It has raised $49.6M in total across 4 rounds, most recently a $23.7M Venture Round in Apr 2025. Investors include JIC Venture Growth Investments, Eight Roads Ventures and F-Prime Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

IPOMar 2026

Sign up to see all 5 events

Funding: Series D through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

J-Pharma on Indexed.vc
<a href="https://indexed.vc/companies/j-pharma"><img src="https://indexed.vc/api/badge/company/j-pharma" alt="J-Pharma on Indexed.vc" width="260" height="76" /></a>